Skip to content

Clinical trials

Phase 1/2 Liver Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Neoplasms Phase: Phase 1/2 Clear all

101 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20015
20021
20033
20042
20054
20061
20074
20082
20093
20101
20112
20123
20135
20146
201510
20164
20172
20182
20193
20201
20213
20229
20234
20244
20256
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed45
Recruiting13
Unknown status13
Terminated11
Withdrawn10
Active, not recruiting5
Not yet recruiting4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fuda Cancer Hospital, Guangzhou8
Jonsson Comprehensive Cancer Center3
M.D. Anderson Cancer Center3
National Cancer Institute (NCI)3
Alliance for Clinical Trials in Oncology2
Eisai Inc.2
Essen Biotech2
Eureka Therapeutics Inc.2
FeRx2
Mirror Biologics, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Neoplasms101
Carcinoma, Hepatocellular44
Colorectal Neoplasms18
Pancreatic Neoplasms16
Breast Neoplasms15
Neoplasm Metastasis15
Stomach Neoplasms14
Lung Neoplasms13
Ovarian Neoplasms11
Neoplasms10

Trials

Showing 1 to 25 of 101. Each trial links to its page on Pharma Observatory.

1 more trial matches. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.